Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Observe Medical – Nya Karolinska Sjukhuset in Sweden resumes the implementation of Sippi® in clinical use at Cardiothoracic ICU unit

Oslo February 22, 2021 – Observe Medical ASA (OSE: OBSERV), announces that Nya Karolinska Sjukhuset in Stockholm, Sweden resumes the implementation of Sippi® in clinical use at the Cardiothoracic ICU unit following a pause during 2020, due to Covid-19    As a result of the recent improvements of the Covid-19 situation at the hospital, the Department of Cardiothoracic Anaesthesiology and Intensive Care at Nya Karolinska Sjukhuset, has decided to resume the implementation of Sippi® in clinical use. The implementation will start in February, and will be done in a stepwise manner, with a

Diamyd Medical makes an investment in MainlyAI

Diamyd Medical’s investment will give a 20% ownership and a board seat in MainlyAI. The investment of SEK 1.2 million will facilitate MainlyAI’s strategic focus on applying artificial intelligence, where the first project is sustainable production within the pharmaceutical sector.As announced in  December 2020, Diamyd Medical and MainlyAI are, together with the Royal Institute of Technology (KTH), engaged in a VINNOVA funded project to design, test and build a sustainability framework powered by artificial intelligence for Diamyd Medical’s production facility in Umeå, Sweden. Ulf

DESENIO PUBLISHES COMPANY DESCRIPTION IN CONNECTION WITH LISTING ON NASDAQ FIRST NORTH GROWTH MARKET AND ANNOUNCES PRIVATE PLACEMENT

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, HONG KONG, CANADA, NEW ZEALAND, JAPAN, SWITZERLAND, SOUTH KOREA OR SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR REQUIRE FURTHER REGISTRATION MEASURES. PLEASE SEE IMPORTANT INFORMATION AT THE END OF THE PRESS RELEASE. Desenio Group AB (publ) (“Desenio” or the “Company”), a fast growing online-based direct-to-consumer company within the global market for affordable wall art, announced on 15 February 2021 its intention

Year-end Report 2020 Redsense Medical AB (publ)

FULL YEAR, 1 JANUARY – 31 DECEMBER 2020 The Redsense Group • Total operating income for the financial year amounted to KSEK 18,159 (14,828). • Net sales for the financial year amounted to KSEK 13,902 (13,265). • Operating result (EBIT) amounted to KSEK -8,024 (-4,594). • Total equity amounted to KSEK 73,166 at the end of the period (14,947). • Cash and cash equivalents amounted to KSEK 29,007 at the end of the period (3,439). The Swedish Parent Company • Total operating income for the financial year amounted to KSEK 12,383 (11,192). • Operating result (EBIT)

‘Advanced automation gives usability and flexibility’: Visiting researcher on DissolvIt

Inhalation researcher Snezana Radivojev from Graz University’s Research Center for Pharmaceutical Engineering (RCPE) has completed a month’s onsite contract research at ISAB’s labs in Stockholm working with the advanced in vitro solution tool DissolvIt[®]. As an in vitro specialist she has spent four years researching a wide range of lung models. How did DissolvIt[®] measure up, and how does her own experience of asthma feed into her research?“I’ve used a wide range of in vitro lung modelling techniques in my research and ISAB’s state-of-the-art DissolvIt[®] is definitely one of the most

Notice of extraordinary general meeting in AB Sagax (publ)

The shareholders of AB Sagax (publ), 556520-0028, (”the Company”) are hereby invited to the Extraordinary General Meeting (EGM) to be held on Friday 19 March 2021. Due to the continued spread of the coronavirus and the authorities’ regulations/advice on avoiding public gatherings, the Board of Directors has resolved that the EGM will be held without physical presence of shareholders, proxies or external parties and that shareholder only can exercise their voting rights by voting in advance in accordance with the procedure prescribed below. Information on the resolutions passed at the EGM

Assemblin Year End Report 2020

“A good end to a strong year in challenging times”Fourth quarter October–December 2020 (compared to October–December 2019) · Net sales in the fourth quarter totalled SEK 2,732 million (2,856). · Adjusted EBITA totalled SEK 232 million (204). The adjusted EBITA margin increased to 8.5 per cent (7.2). · EBITA increased to SEK 219 million (-10). · EBIT increased to SEK 212 million (-18). · Profit after tax amounted to SEK 114 million (-51). · Order intake increased to SEK 2,651 million (2,607). · The order backlog at the end of the period amounted to SEK 8,148 million (8,

Reminder: Invitation to Kongsberg Automotive`s Q4 2020 Earnings Call

Kongsberg Automotive ASA will release its fourth quarter 2020 results on Friday February 26th, 2021 at 07:30 am CET. The company will host an earnings conference call for investors, analysts and media at 09:00 CET, on February 26[th], which will include a review of the Q4 2020 presentation led by Co-CEO’s Norbert Loers and Robert Pigg. After the review, listeners will have the opportunity to ask questions to the presenters. The Q4 earnings call will be available via web and audio, and to access the audio webcast please choose one of the options below: Audience Event Link: https://

Reminder: Invitation to Kongsberg Automotive's Investor Presentation

Kongsberg Automotive ASA will hold an Investor presentation on Friday February 26th, 2021 at 10:30 am CET.  Focus of the presentation is the assessment of current business trends and their impact on Kongsberg Automotive and a brief company overview including its resilience during the COVID-19 crisis followed by product highlights. The presentation will be led by Co-CEO’s Norbert Loers and Robert Pigg.   The investor conference will be available via web and audio, and to access the audio webcast please choose one of the options below: Audience Event Link: https://globalmeet.

Notice of extraordinary general meeting 16 March 2021

Notice is hereby given of an extraordinary general meeting in LED iBond International A/S Reg. no. 36041609 (the “Company”) on 16 March 2021, at 10 o’clock,  to be held electronically with the following Agenda 1. Authorisation of the Board of Directors to increase the share capital (cash) 2. Election to the Board of Directors 3. Authorisation In accordance with section 5.6 of the Articles of Association, the Board of Directors will appoint attorney-at-law Stine Bernt Stryhn as chairperson of the general meeting. Re 1.      Authorisation of the board of

Gasum to supply LNG to Wasaline and to Wärtsilä’s new technology hub

Nordic energy company Gasum has entered into an agreement with the City of Vaasa, NLC Ferry Oy and Wärtsilä Finland Oy to supply liquefied natural gas (LNG) to Wasaline, which operates the Vaasa-Umeå ferry route, and for use in Wärtsilä’s new Smart Technology Hub. Gasum is to build a local LNG customer terminal in Vaskiluoto from where tanker trucks will take LNG to customer sites.Gasum is to build a customer terminal in Vaskiluoto in Vaasa, from where the company will flexibly supply LNG to cargo and passenger shipping company Wasaline’s new LNG-fueled ferry M/S Aurora Botnia, which will

FREYR to Participate in BTIG Energy Transition EV Day Conference

FREYR AS announced today that the company's Chief Executive Officer, Tom Einar Jensen, will attend the BTIG Energy Transition EV Day conference on Tuesday, February 23, 2021. For more information about the conference go to www.btig.com/news. On 29 January 2021 FREYR announced that it will become a publicly listed company through a business combination with Alussa Energy Acquisition Corp., raising $850 million in equity proceeds to accelerate the development clean battery cell manufacturing capacity in Norway. Subject to closing conditions being met, the combined company will be named “

Axactor SE - Acceptances received under mandatory offer

THIS ANNOUNCEMENT IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. Reference is made to the mandatory offer dated 29 January 2021 (the "Mandatory Offer") to acquire all shares in Axactor SE (the "Company") at an offer price of NOK 8.00 per share, made by Geveran Trading Co. Limited, a company indirectly controlled by trusts established by Mr. John Fredriksen for the benefit of his immediate family ("Geveran").  On 19 February 2021,

Initiation of process for capital increase to take advantage of new growth opportunities, updated financial calendar

Facing major new commercial opportunities in the vertical farming and UV-C disinfection markets while at the same time anticipating funding needs for production capacity, spin-offs and continued corona-related uncertainty, LED iBond’s Board of Directors finds it commercially prudent to initiate a process for a capital increase to further strengthen the company’s capital base.Aiming for substantial international growth in coming years, LED iBond International A/S (LED iBond, the “Company”) completed an initial public offering in June 2020 to strengthen the Company’s balance sheet for the

Voluntary withdrawal of Imfinzi indication in advanced bladder cancer in the US

22 February 2021 07:00 GMT Voluntary withdrawal of Imfinzi indicationin advanced bladder cancer in the US AstraZeneca today announced the voluntary withdrawal of the Imfinzi (durvalumab) indication in the US for previously treated adult patients with locally advanced or metastatic bladder cancer. This decision was made in consultation with the Food and Drug Administration (FDA). In May 2017, Imfinzi was granted accelerated approval in the US based on promising tumour response rates and duration of response data from Study 1108, a Phase I/II trial that evaluated the safety and

Össur hf: Final agenda and proposals for the Annual General Meeting 8 March 2021

Announcement no. 05/2021 22 February 2021  Össur hf: Final agenda and proposals for the Annual General Meeting 8 March 2021 Enclosed is the final agenda and proposals for Össur hf.'s Annual General Meeting to be held on Monday 8 March 2021 at 9:00 am (GMT). The Annual General Meeting will be fully virtual as previously announced. No changes have been made to the previously announced agenda and proposals. Further information Investor Relations, IR@ossur.com, +354 515 1300 Össur press releases by e-mail If you wish to receive Össur press releases by e-mail, please

Diaprost Announces Promising New Study for Patients with Metastatic PCa

Diaprost announced today a publication in the journal of Clinical Cancer Research on PSA-targeted Alpha-, Beta- and Positron Emitting Immuno-Theranostics in Murine Prostate Cancer Models and Non-Human Primates.The extensive preclinical study was conducted at Memorial Sloan Kettering Cancer Center (MSK) on Diaprost’s propriety antibody (hu5A10) targeting PSA. This rigorous preclinical evaluation of radiolabeled hu5A10-based compounds in prostate cancer (PCa) mouse models and non-human primates, establishes hu5A10 as a promising theranostic (therapy and diagnostic) agent that allows specific

Scout Gaming signs agreement with ATG

Scout Gaming has entered into an agreement with AB Trav & Galopp, ATG (the Swedish Horse Racing Totalisator Board), Sweden’s largest gaming operator measured by turnover.The companies have agreed to jointly launch Scout Gaming's award-winning DFS product on ATG.se with a soft launch aimed at the second quarter 2021, followed by a wider marketing push in the third quarter, in time for the start of English Premier League and other major European sport leagues. ATG is owned by the Swedish trotting and thoroughbred associations and was the exclusive provider of horse betting on the Swedish

Genova considers issuance of green capital securities and redemption of preference shares

Genova Property Group AB (publ) (the “Issuer” or “Genova”) has mandated ABG Sundal Collier AB (“ABG Sundal Collier”) and Swedbank AB (publ) (“Swedbank”) as joint bookrunners to arrange fixed income investor meetings commencing on 24 February 2021, to investigate the possibility to issue new subordinated perpetual floating rate callable green capital securities in the amount up to SEK 700m, under a framework of SEK 1,250m (“New Capital Securities”). A capital market transaction may follow, subject to, inter alia, market conditions. The Green Finance Framework has been established in

Tokmanni Group Corporation: Notice of Annual General Meeting 2021

Tokmanni Group Corporation        Stock exchange release        22 February 2021 at 9:00 a.m.The shareholders of Tokmanni Group Corporation are hereby invited to the Annual General Meeting to be held on Tuesday 23 March 2021 at 10:00 a.m. at Tokmanni’s administration and logistics centre at the address Isolammintie 1, 04600 Mäntsälä, Finland. It will not be possible to participate in the meeting at the meeting venue, but participation will take place in advance in the manner described in this notice. The Board of Directors of the Company has resolved on exceptional meeting procedures

The board of directors of Scandi Standard has resolved on acquisitions of own shares

The board of directors of Scandi Standard AB (publ) has, based on the authorisation from the annual general meeting 2020, resolved that the company may acquire a maximum of 540,000 own shares on Nasdaq Stockholm. The purpose of acquisitions of own shares shall be to secure delivery of shares to the participants in LTIP 2020 or to hedge costs related to LTIP 2020.Terms and conditions for acquisitions of own sharesAccording to the board of directors’ resolution, any acquisitions of own shares shall be made on Nasdaq Stockholm in accordance with Nasdaq Stockholm’s Rule Book for Issuers and

Elekta establishes office in Egypt to meet growing need for precision radiation medicine

Demand for healthcare services and technology presents strong growth potentialSTOCKHOLM, February 22, 2021 – Elekta (EKTA-B.ST) announced today that it will establish a permanent office in Cairo, Egypt, to address the shortage of radiotherapy delivery systems and software solutions that play an integral part in treating cancer and brain disorders. To strengthen its market leadership and continue providing excellent service to the installed base of more than 40 Elekta radiotherapy solutions, Elekta has signed an agreement to acquire the oncology division of its previous distributor,

Catella advises the Danish state-owned national train service operator DSB in a joint venture development project with Danica

DSB and Danica Pension has formed a joint venture to undertake a 25,000 square meter development project with prime location in the inner city of Copenhagen next to the Central Train Station and Tivoli Gardens.As one of Denmark’s largest landowners, the state-owned national train service operator DSB has adopted a strategy to undertake redevelopment of its real estate portfolio together with experienced joint venture partners. DSB retained Catella Corporate Finance as exclusive financial advisor to prepare business plans, structure joint venture terms and to identify a joint venture

Observe Medical ASA : Invitation to fourth quarter 2020 presentation

Observe Medical ASA invites you to a presentation of the fourth quarter 2020 on Tuesday February 23 at 8.30 CET. Due to the covid-19 situation the presentation will only be held as a webcast. The event will start at 08.30 CET and will be webcasted on www.observemedical.com - Investor relations and on the following link: https://channel.royalcast.com/landingpage/hegnarmedia/20210223_2/ Representatives from the Company will be: CEO Björn Larsson and CFO Per Arne Nygård. Viewers are welcome to ask written questions during and after the presentation through the webcast player.

There are no items matching the current filter
There are no more items matching the current filter
Back to top